Lobbying client
NEUROMOLECULAR PHARMACEUTICALS
Pharmaceutical company
Filings
10
Filed by
1
Reported in-house
—
Reported by firms
$365,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2007 to 2009
Filings
10 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2009
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | $5,000 reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2009
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | $20,000 reported |
|
4th Quarter - Report 4th Quarter 2008
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60,000 reported |
|
3rd Quarter - Report 3rd Quarter 2008
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60,000 reported |
|
2nd Quarter - Report 2nd Quarter 2008
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | $20,000 reported |
|
1st Quarter - Report 1st Quarter 2008
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | $40,000 reported |
|
Year-End Report Year-End 2007
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | $120,000 reported |
|
Registration - Amendment Mid-Year 2007
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | — reported |
|
Mid-Year Report Mid-Year 2007
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | $40,000 reported |
|
Registration Mid-Year 2007
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| BROWNSTEIN HYATT FARBER SCHRECK, LLP | 8 | $365,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Disaster Planning/Emergencies | DIS | 8 |
| Medical/Disease Research/Clinical Labs | MED | 8 |
| Pharmacy | PHA | 8 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.